SI-613 Study for Knee Osteoarthritis

Summary

The objective of the study is to evaluate the efficacy and safety of intra-articular injections of SI-613 compared with placebo for knee OA.

Timeline

Start

2017-10-19

Primary completion

2018-08-17

Completion

2018-11-13

Outcome

Missed primary endpoint

registry analysis (superiority test); SI-613 vs Placebo; p = 0.5453; Least Squares Mean Difference -2.9 (95% CI -12.4 to 6.6); ANCOVA NCT03209362 ↗

Drugs

Indications